-The Hindu Business Line It’s only an open-ended deal with co-developer Bharat Biotech, says top source The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended. Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR’s Pune-based National Institute of Virology...

-TheNewsMinute.com The scientists said that they have received partial funding and permission for implementing systematic surveillance of new variants of Coronavirus. Over 300 scientists from across India, including renowned names like Prof LS Shashidhara (Professor of Biology, IISER Pune and Ashoka University) and Prof Partha Majumder (National Science Chair, Government of India), have requested Prime Minister Narendra Modi to take steps to open access to various data in order to transparency in...

-The Hindu Health, Home dept. officials told of surge in cases, shortage of facilities. Centre has informed all the eight Union Territories that the next three weeks were crucial. The UT administrations including the Delhi Government “were advised to plan in advance for three weeks.” Delhi raised the issue of shortage of beds at a meeting held by the Union Secretaries of Home and Health to review the status of COVID-19 management in...

-The Telegraph The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin India’s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government’s lack of funding for key vaccines under development and evaluation, experts have said. The experts, who have tracked global vaccine efforts, said the Indian government’s lack of investments contrasted with the...

-The Hindu PM chairs meeting; number of new cases crosses 1 lakh. The Russia-made Sputnik V vaccine may be cleared for emergency use in India within 10 days, a highly placed official confirmed to The Hindu on condition of anonymity. The possible approval for a third vaccine candidate comes as Prime Minister Narendra Modi chaired a high-level meeting on Sunday to review the situation and the on-going vaccination programme with the number of...